Meconus-P 750mcg/75mg Tablet
Marketer
Cronus Biotech Ltd
Salt Composition
Methylcobalamin (750mcg) + Pregabalin (75mg)
Overview Meconus-P 750mcg/75mg Tablet
Prenoxal 750mcg/75mg tablets are a prescription medication for neuropathic pain management. It alleviates pain by regulating nerve cell calcium channel function. This medication also safeguards nerve fibers and promotes the repair of damaged nerve cells. Prenoxal 750mcg/75mg tablets are administered orally, with or without food, ideally before sleep. Consistent daily timing helps maintain stable drug levels. Follow your physician's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even if symptoms improve. Abrupt cessation should be avoided without consulting your doctor. Common side effects may include nasal congestion, increased hunger, elevated mood, shaking, visual blurring, dry mouth, lightheadedness, and drowsiness. Avoid activities requiring concentration until the medication's effects are known. Side effects are generally mild and improve over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal thoughts to your doctor. Disclose all other medications being taken, as interactions may reduce efficacy or alter the drug's action. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Meconus-P 750mcg/75mg Tablet
Managing neuropathic pain
Major Benefits of Meconus-P 750mcg/75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Meconus-P 750mcg/75mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, however, consistent daily timing is recommended.
Common Side effects of Meconus-P 750mcg/75mg Tablet:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Meconus-P 750mcg/75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and duration outlined. Ingest the Meconus-P 750mcg/75mg Tablet whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable, though consistent timing is recommended.
How Meconus-P 750mcg/75mg Tablet works:
Each Meconus-P 750mcg/75mg tablet unites methylcobalamin (a vitamin B variant) and pregabalin. Methylcobalamin aids myelin production, protecting nerve fibers and fostering nerve cell repair. Pregabalin, an alpha-2-delta ligand, alleviates pain by modulating nerve cell calcium channel activity. This combined action provides relief from neuropathic pain stemming from nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Meconus-P 750mcg/75mg tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Meconus-P 750mcg/75mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Meconus-P 750mcg/75mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Meconus-P 750mcg/75mg tablets might reduce awareness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should use Meconus-P 750mcg/75mg Tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Meconus-P 750mcg/75mg tablets in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is advised.
What if you forget to take Meconus-P 750mcg/75mg Tablet :
Should you forget a dose of Meconus-P 750mcg/75mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Meconus-P 750mcg/75mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience and Central Nervous System |
3,018 People bought this recently